Establishing a new human lung squamous cell carcinoma cell line, OMUL‐1, expressing insulin‐like growth factor 1 receptor and programmed cell death ligand 1

Abstract The Main Problem Squamous cell carcinoma is the second most prevalent type of non–small cell lung cancer. Analyzing the molecular mechanisms underlying lung carcinoma requires useful tools, such as squamous lung cancer cell lines. Methods A novel new lung squamous cell carcinoma cell line,...

Full description

Saved in:
Bibliographic Details
Main Authors: Hiroaki Nagamine, Masakazu Yashiro, Megumi Mizutani, Akira Sugimoto, Yoshiya Matsumoto, Yoko Tani, Hiroyasu Kaneda, Kazuhiro Yamada, Tetsuya Watanabe, Kazuhisa Asai, Satoshi Suzuki, Tomoya Kawaguchi
Format: Article
Language:English
Published: Wiley 2025-01-01
Series:Thoracic Cancer
Subjects:
Online Access:https://doi.org/10.1111/1759-7714.15488
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850030325407678464
author Hiroaki Nagamine
Masakazu Yashiro
Megumi Mizutani
Akira Sugimoto
Yoshiya Matsumoto
Yoko Tani
Hiroyasu Kaneda
Kazuhiro Yamada
Tetsuya Watanabe
Kazuhisa Asai
Satoshi Suzuki
Tomoya Kawaguchi
author_facet Hiroaki Nagamine
Masakazu Yashiro
Megumi Mizutani
Akira Sugimoto
Yoshiya Matsumoto
Yoko Tani
Hiroyasu Kaneda
Kazuhiro Yamada
Tetsuya Watanabe
Kazuhisa Asai
Satoshi Suzuki
Tomoya Kawaguchi
author_sort Hiroaki Nagamine
collection DOAJ
description Abstract The Main Problem Squamous cell carcinoma is the second most prevalent type of non–small cell lung cancer. Analyzing the molecular mechanisms underlying lung carcinoma requires useful tools, such as squamous lung cancer cell lines. Methods A novel new lung squamous cell carcinoma cell line, OMUL‐1, was developed from the primary lung cancer of a 74‐year‐old man. We assessed the characteristics and behavior of OMUL‐1 cells were examined, including their growth kinetics, tumorigenicity in mice, histological properties, gene expression profiles using reverse transcription polymerase chain reaction (RT‐PCR), and RNA sequencing and invasion assays. Results OMUL‐1‐an adherent cell line‐resulted in 100% tumor formation when subcutaneously injected into mice. Histological analysis of the subcutaneous tumor using hematoxylin and eosin staining revealed squamous cell carcinoma with characteristics similar to those of the primary tumor (p40 and p63 were positive, and TTF‐1 was negative). An invasion assay demonstrated that OMUL‐1 had a lower invasion ability compared to that of other developed cell lines. RT‐PCR analysis and RNA sequencing indicated that OMUL‐1 cells expressed FGFR1, FGFR2, FGFR3, FGFR4, EGFR, HER2, ErbB3, ErbB4, VEGFR3, IGF1R, c‐MET, PDGFRa, and PDGFRb. Additionally, picropodophyllin (an IGF1R inhibitor) significantly inhibited the growth of OMUL‐1 cells. Immunohistochemistry revealed that IGF1R and PD‐L1 were expressed in both the primary and subcutaneous tumors. Conclusions We developed a novel new squamous cell lung carcinoma cell line, OMUL‐1, that expresses IGF1R and PD‐L1.
format Article
id doaj-art-5cdf0614865742409c71621fc7bc147d
institution DOAJ
issn 1759-7706
1759-7714
language English
publishDate 2025-01-01
publisher Wiley
record_format Article
series Thoracic Cancer
spelling doaj-art-5cdf0614865742409c71621fc7bc147d2025-08-20T02:59:14ZengWileyThoracic Cancer1759-77061759-77142025-01-01161n/an/a10.1111/1759-7714.15488Establishing a new human lung squamous cell carcinoma cell line, OMUL‐1, expressing insulin‐like growth factor 1 receptor and programmed cell death ligand 1Hiroaki Nagamine0Masakazu Yashiro1Megumi Mizutani2Akira Sugimoto3Yoshiya Matsumoto4Yoko Tani5Hiroyasu Kaneda6Kazuhiro Yamada7Tetsuya Watanabe8Kazuhisa Asai9Satoshi Suzuki10Tomoya Kawaguchi11Department of Respiratory Medicine, Graduate School of Medicine Osaka Metropolitan University Osaka JapanMolecular Oncology and Therapeutics, Graduate School of Medicine Osaka Metropolitan University Osaka JapanDepartment of Respiratory Medicine, Graduate School of Medicine Osaka Metropolitan University Osaka JapanDepartment of Respiratory Medicine, Graduate School of Medicine Osaka Metropolitan University Osaka JapanDepartment of Respiratory Medicine, Graduate School of Medicine Osaka Metropolitan University Osaka JapanDepartment of Clinical Oncology, Graduate School of Medicine Osaka Metropolitan University Osaka JapanDepartment of Clinical Oncology, Graduate School of Medicine Osaka Metropolitan University Osaka JapanDepartment of Respiratory Medicine, Graduate School of Medicine Osaka Metropolitan University Osaka JapanDepartment of Respiratory Medicine, Graduate School of Medicine Osaka Metropolitan University Osaka JapanDepartment of Respiratory Medicine, Graduate School of Medicine Osaka Metropolitan University Osaka JapanDepartment of Thoracic Surgery, Graduate School of Medicine Osaka Metropolitan University Osaka JapanDepartment of Respiratory Medicine, Graduate School of Medicine Osaka Metropolitan University Osaka JapanAbstract The Main Problem Squamous cell carcinoma is the second most prevalent type of non–small cell lung cancer. Analyzing the molecular mechanisms underlying lung carcinoma requires useful tools, such as squamous lung cancer cell lines. Methods A novel new lung squamous cell carcinoma cell line, OMUL‐1, was developed from the primary lung cancer of a 74‐year‐old man. We assessed the characteristics and behavior of OMUL‐1 cells were examined, including their growth kinetics, tumorigenicity in mice, histological properties, gene expression profiles using reverse transcription polymerase chain reaction (RT‐PCR), and RNA sequencing and invasion assays. Results OMUL‐1‐an adherent cell line‐resulted in 100% tumor formation when subcutaneously injected into mice. Histological analysis of the subcutaneous tumor using hematoxylin and eosin staining revealed squamous cell carcinoma with characteristics similar to those of the primary tumor (p40 and p63 were positive, and TTF‐1 was negative). An invasion assay demonstrated that OMUL‐1 had a lower invasion ability compared to that of other developed cell lines. RT‐PCR analysis and RNA sequencing indicated that OMUL‐1 cells expressed FGFR1, FGFR2, FGFR3, FGFR4, EGFR, HER2, ErbB3, ErbB4, VEGFR3, IGF1R, c‐MET, PDGFRa, and PDGFRb. Additionally, picropodophyllin (an IGF1R inhibitor) significantly inhibited the growth of OMUL‐1 cells. Immunohistochemistry revealed that IGF1R and PD‐L1 were expressed in both the primary and subcutaneous tumors. Conclusions We developed a novel new squamous cell lung carcinoma cell line, OMUL‐1, that expresses IGF1R and PD‐L1.https://doi.org/10.1111/1759-7714.15488cell lineIGF1Rlung cancerPD‐L1squamous cell carcinoma
spellingShingle Hiroaki Nagamine
Masakazu Yashiro
Megumi Mizutani
Akira Sugimoto
Yoshiya Matsumoto
Yoko Tani
Hiroyasu Kaneda
Kazuhiro Yamada
Tetsuya Watanabe
Kazuhisa Asai
Satoshi Suzuki
Tomoya Kawaguchi
Establishing a new human lung squamous cell carcinoma cell line, OMUL‐1, expressing insulin‐like growth factor 1 receptor and programmed cell death ligand 1
Thoracic Cancer
cell line
IGF1R
lung cancer
PD‐L1
squamous cell carcinoma
title Establishing a new human lung squamous cell carcinoma cell line, OMUL‐1, expressing insulin‐like growth factor 1 receptor and programmed cell death ligand 1
title_full Establishing a new human lung squamous cell carcinoma cell line, OMUL‐1, expressing insulin‐like growth factor 1 receptor and programmed cell death ligand 1
title_fullStr Establishing a new human lung squamous cell carcinoma cell line, OMUL‐1, expressing insulin‐like growth factor 1 receptor and programmed cell death ligand 1
title_full_unstemmed Establishing a new human lung squamous cell carcinoma cell line, OMUL‐1, expressing insulin‐like growth factor 1 receptor and programmed cell death ligand 1
title_short Establishing a new human lung squamous cell carcinoma cell line, OMUL‐1, expressing insulin‐like growth factor 1 receptor and programmed cell death ligand 1
title_sort establishing a new human lung squamous cell carcinoma cell line omul 1 expressing insulin like growth factor 1 receptor and programmed cell death ligand 1
topic cell line
IGF1R
lung cancer
PD‐L1
squamous cell carcinoma
url https://doi.org/10.1111/1759-7714.15488
work_keys_str_mv AT hiroakinagamine establishinganewhumanlungsquamouscellcarcinomacelllineomul1expressinginsulinlikegrowthfactor1receptorandprogrammedcelldeathligand1
AT masakazuyashiro establishinganewhumanlungsquamouscellcarcinomacelllineomul1expressinginsulinlikegrowthfactor1receptorandprogrammedcelldeathligand1
AT megumimizutani establishinganewhumanlungsquamouscellcarcinomacelllineomul1expressinginsulinlikegrowthfactor1receptorandprogrammedcelldeathligand1
AT akirasugimoto establishinganewhumanlungsquamouscellcarcinomacelllineomul1expressinginsulinlikegrowthfactor1receptorandprogrammedcelldeathligand1
AT yoshiyamatsumoto establishinganewhumanlungsquamouscellcarcinomacelllineomul1expressinginsulinlikegrowthfactor1receptorandprogrammedcelldeathligand1
AT yokotani establishinganewhumanlungsquamouscellcarcinomacelllineomul1expressinginsulinlikegrowthfactor1receptorandprogrammedcelldeathligand1
AT hiroyasukaneda establishinganewhumanlungsquamouscellcarcinomacelllineomul1expressinginsulinlikegrowthfactor1receptorandprogrammedcelldeathligand1
AT kazuhiroyamada establishinganewhumanlungsquamouscellcarcinomacelllineomul1expressinginsulinlikegrowthfactor1receptorandprogrammedcelldeathligand1
AT tetsuyawatanabe establishinganewhumanlungsquamouscellcarcinomacelllineomul1expressinginsulinlikegrowthfactor1receptorandprogrammedcelldeathligand1
AT kazuhisaasai establishinganewhumanlungsquamouscellcarcinomacelllineomul1expressinginsulinlikegrowthfactor1receptorandprogrammedcelldeathligand1
AT satoshisuzuki establishinganewhumanlungsquamouscellcarcinomacelllineomul1expressinginsulinlikegrowthfactor1receptorandprogrammedcelldeathligand1
AT tomoyakawaguchi establishinganewhumanlungsquamouscellcarcinomacelllineomul1expressinginsulinlikegrowthfactor1receptorandprogrammedcelldeathligand1